Literature DB >> 10362677

Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts.

T Yokoyama1, K Sekiguchi, T Tanaka, K Tomaru, M Arai, T Suzuki, R Nagai.   

Abstract

To determine whether ANG II as well as mechanical stress affect the production of tumor necrosis factor (TNF) in the heart, neonatal rat cardiac myocytes and fibroblasts were cultured separately and treated for 6 h with ANG II, lipopolysaccharide (LPS), or cyclic mechanical stretch. LPS induced the production of TNF in cardiac myocytes and fibroblasts. However, TNF synthesis in fibroblasts was 20- to 40-fold higher than in myocytes. ANG II (>/=10(-8) M) and mechanical stretch stimulated the production of TNF in cardiac fibroblasts but not in myocytes. Furthermore, both ANG II and LPS increased the expression of TNF-alpha mRNA in cardiac fibroblasts. Isoproterenol inhibited both LPS- and ANG II-induced production of TNF in cardiac fibroblasts with increasing intracellular cAMP level. Moreover, both isoproterenol and dibutyryl cAMP inhibited LPS-induced TNF-alpha mRNA expression. Thus activation of the renin-angiotensin system, as well as mechanical stress, can stimulate production of TNF in cardiac fibroblasts. Furthermore, beta-adrenergic receptors may be responsible for the regulation of TNF synthesis at the transcriptional level by elevating intracellular cAMP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362677     DOI: 10.1152/ajpheart.1999.276.6.H1968

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  29 in total

1.  Mechanical overload-induced apoptosis: a study in cultured neonatal ventricular myocytes and fibroblasts.

Authors:  Marion Persoon-Rothert; Karlien G C van der Wees; Arnoud van der Laarse
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

2.  TNF alpha is required for hypoxia-mediated right ventricular hypertrophy.

Authors:  R M Smith; J McCarthy; M N Sack
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

3.  Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice.

Authors:  Dominic P Del Re; Takahisa Matsuda; Peiyong Zhai; Shumin Gao; Geoffrey J Clark; Louise Van Der Weyden; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

4.  Agent-based computational model investigates muscle-specific responses to disuse-induced atrophy.

Authors:  Kyle S Martin; Silvia S Blemker; Shayn M Peirce
Journal:  J Appl Physiol (1985)       Date:  2015-02-26

Review 5.  Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications.

Authors:  A P Bolger; S D Anker
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

6.  Combination stem cell therapy for heart failure.

Authors:  Thomas E Ichim; Fabio Solano; Fabian Lara; Jorge Paz Rodriguez; Octav Cristea; Boris Minev; Famela Ramos; Erik J Woods; Michael P Murphy; Doru T Alexandrescu; Amit N Patel; Neil H Riordan
Journal:  Int Arch Med       Date:  2010-04-14

7.  The dynamics of fibroblast-myocyte-capillary interactions in the heart.

Authors:  Stephanie L K Bowers; Thomas K Borg; Troy A Baudino
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 8.  Molecular mechanisms of angiotensin II-induced vascular injury.

Authors:  Marta Ruiz-Ortega; Monica Ruperez; Vanesa Esteban; Jesús Egido
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

Review 9.  Cardiac fibroblast: the renaissance cell.

Authors:  Colby A Souders; Stephanie L K Bowers; Troy A Baudino
Journal:  Circ Res       Date:  2009-12-04       Impact factor: 17.367

10.  Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes.

Authors:  Kalyani D Panse; Leanne E Felkin; Marina M López-Olañeta; Jesús Gómez-Salinero; María Villalba; Lucía Muñoz; Kazuto Nakamura; Masayuki Shimano; Kenneth Walsh; Paul J R Barton; Nadia Rosenthal; Enrique Lara-Pezzi
Journal:  J Cardiovasc Transl Res       Date:  2012-08-23       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.